INNODIA DETECT the time is now
If you're here, it means you recognize the power of early detection in reshaping the future of type 1 diabetes (T1D). We are on the cusp of a groundbreaking shift.
- A turning point has arrived. The medical community now acknowledges the critical importance of pre-symptomatic T1D, reflected in the assignment of ICD-10 codes, underscoring the need for clinical oversight.
- Momentum is building. The first therapy proven to delay the onset of symptomatic T1D has been approved in some countries, and it is progressing through European regulatory processes.
- The time for action is now. Clinical trials for disease-modifying therapies are expanding rapidly, and identifying individuals with early T1D has never been more urgent.
To seize this momentum and push the boundaries of early-stage T1D detection, INNODIA is driving two major initiatives:
The INNODIA Family & Friends early T1D detection program
In compliance with the international guidelines [1], INNODIA developed two master protocols that enable clinical sites to implement early T1D detection with confidence and consistency. The INNODIA Family & Friends early T1D detection program (INNODIA DETECT) will be rolled out across all INNODIA clinical sites and provide harmonized guidance for early T1D detection. This includes: (i) master protocols for islet auto-antibody (IAb) detection and monitoring of IAb+ individuals, (ii) access to a centralized data repository (INNODIA eCRF) for streamlined data collection, and (iii) matchmaking support to connect clinical trials' Sponsors with the clinical sites monitoring pre-symptomatic T1D individuals.
Our goal?
To ensure every clinical site interested in IAb screening has a clear, actionable roadmap to follow.
Here's what to do:
Whether your clinical site is an INNODIA member waiting to be activated within the INNODIA Family & Friends Early T1D Detection Program or you are not part of our network yet, we are making our master protocols available to everyone. If you are interested in implementing early T1D detection at your site, download the protocol from this page and start taking action today.
The Early T1D Navigator Tool
INNODIA is creating a comprehensive database to map screening and monitoring activities across Europe. The Early T1D Navigator Tool will connect individuals interested in getting screened or monitored to clinical sites in our database offering these programs.
We’re now reaching out to clinical sites to be listed in this growing resource!
- Is your site conducting IAb detection or IAb+ monitoring initiatives?
- Would you like to increase your center’s visibility and connect with more individuals interested in these programs?
Click here to fill out the form and add your site to our database, making it easily discoverable through the Early T1D Navigator!
By equipping clinical sites with tools and frameworks, INNODIA is ensuring that people with pre-symptomatic T1D are identified, monitored, and offered clinical trials or therapies when available
If your site is ready to be part of this revolution in T1D care, join us in this transformative effort!
The future of T1D starts today
Let’s make it happen together
